Statistics

Total Visits

Views
Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by21

Select a period of time:

Number of views in the range

Views
Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by13

Views

Views
November 20240
December 20240
January 20251
February 20250
March 202510
April 20252
May 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore10
United States2
Spain1
 

Top cities views

Views
Council Bluffs1